Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MPhoPho

ABSTRACT: Phocoena phocoena (harbor porpoise), genomic and transcriptomic data

PROVIDER: PRJEB71541 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR12408792.fastq.gz	Fastqsanger.gz
	ERR12408793.fastq.gz	Fastqsanger.gz
	ERR12512736_1.fastq.gz	Fastqsanger.gz
	ERR12512736_2.fastq.gz	Fastqsanger.gz
	ERR12512737_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

mPhoPho

Project description:Phocoena phocoena (harbor porpoise)

| PRJEB71542 | ENA

mPhoPho1

Project description:Phocoena phocoena (harbor porpoise) genome assembly, mPhoPho1

| PRJEB72090 | ENA

mPhoPho1 alternate haplotype

Project description:Phocoena phocoena (harbor porpoise) genome assembly, mPhoPho1, alternate haplotype

| PRJEB72091 | ENA

Project description:Isolation, associated pathology and genomic characterization of cetacean picornavirus, a novel picornavirus species from a beluga whale (Delphinapterus leucas) and a harbor porpoise (Phocoena phocoena) from Alaska

| PRJNA1001932 | ENA

Transcriptomes of novel human genomic safe harbor sites for gene and cell therapies

Project description:Bulk RNA-sequencing experiments were performed to analyze the transcriptomic effects of such integrations into two newly established genomic safe harbor sites. Jurkat and HEK293T cells were edited to integrate CMV-mRuby expressing cassette into Rogi2 genomic safe harbor site using Cas9 RNP

2022-02-11 | E-MTAB-11289 | biostudies-arrayexpress

Phocoena phocoena

Project description:Phocoena phocoena overview

| PRJNA343998 | ENA

Phocoena phocoena

Project description:Phocoena phocoena ddRADSeq raw sequence reads

| PRJNA343959 | ENA

Phocoena phocoena

Project description:Phocoena phocoena Genome sequencing and assembly

| PRJNA417595 | ENA

Project description:Phocoena sinus (Vaquita) genome, mPhoSin1, sequence data

| PRJNA1008625 | ENA

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Project description:The purpose of this clinical study is to establish the safety profile, determine the maximum tolerated dose (MTD) and recommend a Phase 2 dose and schedule of SRA737; and to evaluate the efficacy of SRA737 in prospectively-selected subjects with genetically-defined tumors that harbor genomic alterations linked to increased replication stress and that are hypothesized to be more sensitive to checkpoint kinase 1 (Chk1) inhibition via synthetic lethality. Specific cancer indications that frequently harbor these genetic mutations will be studied.

| 2217119 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data